Factor | p value |
---|---|
Sex. | |
Male:female | 0.0803 |
Age (years) ≤ 69 vs ≥ 70 | 0.8002 |
Symptomatic level Cervical vs thoracic vs lumbosacral | 0.1603 |
Pathology Adenocarcinoma vs non-adenocarcinoma | 0.0263* |
Tokuhashi score | |
General condition | |
Poor vs good | 0.0019* |
Moderate vs good | 0.0321* |
Number of extraspinal bone metastases foci | 0.9604 |
Number of metastases in the vertebral body | 0.1388 |
Metastases to the major internal organs | 0.6994 |
Paralysis (spinal cord palsy) | 0.0279* |
Total score ≤ 8 vs 9–10 | 0.1542 |
ALP 400 IU/L ≥ or < | 0.0961 |
CEA 120 ng/ml ≥ or < | 0.5189 |
Molecular target drug, use (for ≥ 1 month) or not | 0.0093* |
Bone-modifying agent, use or not | 0.8650 |